Wave Life Sciences Ltd.·4

Mar 5, 5:14 PM ET

Vargeese Chandra 4

4 · Wave Life Sciences Ltd. · Filed Mar 5, 2025

Insider Transaction Report

Form 4
Period: 2025-03-04
Vargeese Chandra
See Remarks
Transactions
  • Exercise/Conversion

    Share Option (right to buy)

    2025-03-0475,3320 total
    Exercise: $2.48Exp: 2025-03-10Ordinary Shares (75,332 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2025-03-04$2.48/sh+91,754$227,550362,687 total
  • Exercise/Conversion

    Share Option (right to buy)

    2025-03-0416,4220 total
    Exercise: $2.48Exp: 2025-03-10Ordinary Shares (16,422 underlying)
Footnotes (1)
  • [F1]The share options that were exercised via cash purchase in this reportable transaction were fully vested.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4